53 related articles for article (PubMed ID: 29631806)
1. Hypolipidemic effect and gut microbiota regulation of Gypenoside aglycones in rats fed a high-fat diet.
Xie J; Luo M; Chen Q; Zhang Q; Qin L; Wang Y; Zhao Y; He Y
J Ethnopharmacol; 2024 Jun; 328():118066. PubMed ID: 38499259
[TBL] [Abstract][Full Text] [Related]
2. [Research on mechanism of hypolipidemic effect of Massa Medicata Fermentata based on metabolomics].
Liu JH; Tian YY; Zhao XY; Li YL; Lyu YN; Liu C; Lin ZZ; Wang ZJ; Zuo ZP; Wang ZB
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):770-778. PubMed ID: 38621881
[TBL] [Abstract][Full Text] [Related]
3. Integrated metabolomics and network pharmacology to reveal the lipid-lowering mechanisms of Qizha Shuangye granules in hyperlipidemic rats.
Zhao L; Wang S; Xu X; Guo W; Yang J; Liu Y; Xie S; Piao G; Xu T; Wang Y; Xu Y
J Sci Food Agric; 2024 Apr; 104(6):3265-3274. PubMed ID: 38087399
[TBL] [Abstract][Full Text] [Related]
4. The Heart Protection Effect of Alcalase Potato Protein Hydrolysate Is through IGF1R-PI3K-Akt Compensatory Reactivation in Aging Rats on High Fat Diets.
Hu WS; Ting WJ; Chiang WD; Pai P; Yeh YL; Chang CH; Lin WT; Huang CY
Int J Mol Sci; 2015 May; 16(5):10158-72. PubMed ID: 25950762
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics analysis delineates the therapeutic effects of Yinlan Tiaozhi capsule on triton WR-1339 -induced hyperlipidemia in mice.
Xiao G; Xu A; Jiang J; Chen Z; Li Y; Li S; Chen W; Zhang J; Jia C; Zeng Z; Bi X
Front Pharmacol; 2023; 14():1252146. PubMed ID: 37964876
[TBL] [Abstract][Full Text] [Related]
6. Danggui Shaoyao San ameliorates the lipid metabolism via the PPAR signaling pathway in a Danio rerio (zebrafish) model of hyperlipidemia.
Wang Y; Pan Y; Hou M; Luo R; He J; Lin F; Xia X; Li P; He C; He P; Cheng S; Song Z
Biomed Pharmacother; 2023 Dec; 168():115736. PubMed ID: 37852100
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of traditional Chinese medicine containing hawthorn for hyperlipidemia: a systematic review and meta-analysis.
Zhou X; Chen C; Gao Z; Qian Z; Miao J
Toxicol Res (Camb); 2024 Apr; 13(2):tfae035. PubMed ID: 38482041
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a quality marker (Q-marker) system for Chinese herbal medicines using burdock as an example.
Kang T; Dou D; Xu L
Phytomedicine; 2019 Feb; 54():339-346. PubMed ID: 30318153
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potential Q-marker of traditional Chinese medicine based on plant metabolomics and network pharmacology: Periplocae Cortex as an example.
Li ZT; Zhang FX; Fan CL; Ye MN; Chen WW; Yao ZH; Yao XS; Dai Y
Phytomedicine; 2021 May; 85():153535. PubMed ID: 33819766
[TBL] [Abstract][Full Text] [Related]
10. Quality evaluation methods of chinese medicine based on scientific supervision: recent research progress and prospects.
Chen Z; Vong CT; Zhang T; Yao C; Wang Y; Luo H
Chin Med; 2023 Sep; 18(1):126. PubMed ID: 37777788
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties and underlying mechanisms of aurantio‑obtusin (Review).
Liu Y; Sun X; Hu X; Xu Y; Li T; Wu Z
Exp Ther Med; 2023 Aug; 26(2):380. PubMed ID: 37456169
[TBL] [Abstract][Full Text] [Related]
12. Combining effect of camellia oil and squalene on hyperlipidemia-induced reproductive damage in male rats.
Xu Q; Luo M; Cheng G; Zhong Q; Guo Y; Luo J
Front Nutr; 2022; 9():1053315. PubMed ID: 36466393
[TBL] [Abstract][Full Text] [Related]
13. Discovery and identification of quality markers of
Xu N; Sun R; Shi YP; Han LW; Shi HY
Chin Herb Med; 2021 Jul; 13(3):389-395. PubMed ID: 36118923
[TBL] [Abstract][Full Text] [Related]
14. Antihyperlipidemic and hepatoprotective properties of alkali- and enzyme-extractable polysaccharides by Dictyophora indusiata.
Wang W; Liu H; Zhang Y; Feng Y; Yuan F; Song X; Gao Z; Zhang J; Song Z; Jia L
Sci Rep; 2019 Oct; 9(1):14266. PubMed ID: 31582800
[TBL] [Abstract][Full Text] [Related]
15. An automatic diagnostic system based on deep learning, to diagnose hyperlipidemia.
Zhang Q; Liu Y; Liu G; Zhao G; Qu Z; Yang W
Diabetes Metab Syndr Obes; 2019; 12():637-645. PubMed ID: 31118725
[No Abstract] [Full Text] [Related]
16. Determination of quality markers of Xuezhiling tablet for hyperlipidemia treatment.
Nie C; Zhang F; Ma X; Guo R; Zhou S; Zhao L; Xu H; Xiao X; Wang Z
Phytomedicine; 2018 May; 44():231-238. PubMed ID: 29631806
[TBL] [Abstract][Full Text] [Related]
17. Selection and evaluation of quality markers from Yinlan capsule and its LXRα-mediated therapy for hyperlipidemia.
Chen Z; Sun D; Bi X; Luo W; Xu A; Chen W; Jiang J; Cai D; Guo H; Cao L
Phytomedicine; 2019 Jun; 59():152896. PubMed ID: 30978649
[TBL] [Abstract][Full Text] [Related]
18. Screening of hypolipidemic active components in Jiang-Zhi-Ning and its preliminary mechanism research based on "active contribution value" study.
Zhang Y; Li L; Zhang J; Lin T; Jiang Y; Liu B
J Ethnopharmacol; 2021 May; 272():113926. PubMed ID: 33596472
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
